Company Search
Search Results
Purchase Options

Selected Company

Cogentus Pharmaceuticals, Inc. (FKA: Amplify Therapeutics)

Menlo Park, CA

Operates as a pharmaceutical company. The Company develops fixed-dose combination prescription medicines. It has begun establishing sites and recruiting patients for the first phase 3 clinical trial of its compound CGT-2168. A combination medicine pairing clopidogrel (marketed as Plavix by Bristol-Myers Squibb Co. and Sanofi-Aventis) with a gastroprotectant in a single pill, CGT-2168 is designed to reduce the gastrointestinal side effects commonly associated with dual antiplatelet therapy.

Geographic Region: Silicon Valley

Industry Sector: Biotechnology

Capital Invested: 57mm

Number of Financings: 3

Most Recent Financing: December 31, 2007

Purchase Options

1 Month KIT Access - $325.00 Access complete data for this and all other companies in KIT for one month (no commitment required). If you need more information about KIT, please see both the "Using KIT" section and the Sample Company Report. If you need more than one license to KIT or an extended license, please call 646-290-9254.		12 Month KIT Access - Best Value! Access complete data for this and all other companies in KIT for 12 months. If you need more than one license to KIT or an extended license, please call 646-290-9254.

What Is KIT?

K.I.T. reveals valuations, investment data and the terms, investors, and analytics of each venture-backed deal. Search by: industry sector, geographic location, or financing round - and K.I.T. will match it to our internal dataset of deal terms. Download the charter certificate in PDF for each company. Data, Analytics, Deal Terms. We Make Private Equity Public.

How Does KIT Work?

K.I.T. reveals investment data and the terms, investors, and analytics of each deal. Search by: industry sector, geographic location, or financing round - and K.I.T. will match it to our internal dataset of deal terms. Download the charter certificate in PDF for each company. Data, Analytics, Deal Terms. We Make Private Equity Public.

Business Intellegence

We can provide business intelligence to private equity and venture investors, hedge funds and other debt and equity investors by data mining our proprietary database. Under normal circumstances, these reports are delivered in a digital report format within 36 hours of the request. Call our analyst team at 646-290-9254 to see how we can assist you with your next business transaction.